Clinical Trial Update: Interaction of Docetaxel and Lonafarnib in Patients With Advanced Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the interaction of docetaxel and lonafarnib in patients with advanced cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colorectal Cancer
• Lung Cancer
• Prostate Cancer
• Soft Tissue Sarcoma

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Lonafarnib (lonafarnib)

Snippet

Sponsor: Emory University | Conditions: Lung Cancer, Soft Tissue Sarcoma | Phase 1 | Status: TERMINATED